KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Tae Won Kim
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 17건 중 1-17 번을 표시중입니다.
1
Article
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer
Dong-In Koh
;
Ji Hee Gong
;
DO Yeon Kim
;
et al
2022
2
Article
Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice
Hyehyun Jeong
;
Eunjung Lee
;
Deokhoon Kim
;
et al
2022
3
Article
Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study
Hyungwoo Cho
;
Jeong Eun Kim
;
Yong Sang Hong
;
et al
2022
4
Article
Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment
Hyung-Don Kim
;
Sun Young Kim
;
Jihun Kim
;
et al
2022
5
Article
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
Eunyoung Tak
;
Minhee Kim
;
Youngra Cho
;
et al
2022
6
Article
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim
;
Howard A Burris
;
Maria J de Miguel Luken
;
et al
2022
7
Article
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
Filip Janku
;
Seung-Hoon Beom
;
Yong Wha Moon
;
et al
2022
8
Article
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer
Jaewon Hyung
;
Eun Jeong Cho
;
Jihun Kim
;
et al
2022
9
Article
Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy
Jeong Eun Kim
;
Ji-Hun Kim
;
Sang-Yeob Kim
;
et al
2022
10
Article
Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions for determining TME quality
Jin Cheon Kim
;
Seong Ho Park
;
Jihun Kim
;
et al
2022
11
Article
Molecular characterization of dysplasia-initiated colorectal cancer with assessing matched tumor and dysplasia samples
Sungwon Jung
;
Jong Lyul Lee
;
Tae Won Kim
;
et al
2022
12
Article
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
Seung Tae Kim
;
Sun Young Kim
;
Jeeyun Lee
;
et al
2022
13
Article
Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer
Chung Ryul Oh
;
Jeong Eun Kim
;
Yong Sang Hong
;
et al
2022
14
Article
Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases
Jesang Yu
;
Dong Hwan Kim
;
Jungbok Lee
;
et al
2022
15
Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
Shinkyo Yoon
;
Miso Kim
;
Yong Sang Hong
;
et al
2022
16
Article
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Marwan G Fakih
;
Scott Kopetz
;
Yasutoshi Kuboki
;
et al
2022
17
Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study
Jwa Hoon Kim
;
Seyoung Seo
;
Jee Hyun Kim
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide